BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28142295)

  • 41. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
    Oudejans JJ; van Wieringen WN; Smeets SJ; Tijssen M; Vosse SJ; Meijer CJ; Meijer GA; van de Wiel MA; Ylstra B
    Genes Chromosomes Cancer; 2009 Mar; 48(3):250-60. PubMed ID: 19051311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles.
    Yang XH; Wang B; Cunningham JM
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S6. PubMed ID: 26043758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.
    Franke NE; Kaspers GL; Assaraf YG; van Meerloo J; Niewerth D; Kessler FL; Poddighe PJ; Kole J; Smeets SJ; Ylstra B; Bi C; Chng WJ; Horton TM; Menezes RX; Musters RJ; Zweegman S; Jansen G; Cloos J
    Oncotarget; 2016 Nov; 7(46):74779-74796. PubMed ID: 27542283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
    Kim SY; Shin DY; Kim SM; Lee M; Kim EJ
    Leuk Res; 2016 Aug; 47():116-22. PubMed ID: 27318093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood acute lymphoblastic leukemia: is there a tumor suppressor gene in chromosome 12p12.3?
    Aïssani B; Bonan C; Baccichet A; Sinnett D
    Leuk Lymphoma; 1999 Jul; 34(3-4):231-9. PubMed ID: 10439360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
    Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
    Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region.
    Lilljebjörn H; Heidenblad M; Nilsson B; Lassen C; Horvat A; Heldrup J; Behrendtz M; Johansson B; Andersson A; Fioretos T
    Leukemia; 2007 Oct; 21(10):2137-44. PubMed ID: 17690704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
    Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: prognostication or protocol selection?
    Catchpoole D; Guo D; Jiang H; Biesheuvel C
    Blood; 2008 Feb; 111(4):2486-7; author reply 2487-8. PubMed ID: 18263786
    [No Abstract]   [Full Text] [Related]  

  • 54. Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies.
    Kong X; Zhai J; Yan C; Song Y; Wang J; Bai X; Brown JAL; Fang Y
    Front Oncol; 2019; 9():234. PubMed ID: 31214487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crossing our Ts: An unusual presentation of infantile T-cell leukemia.
    Rahim MQ; Colace S; Belsky JA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29263. PubMed ID: 34310014
    [No Abstract]   [Full Text] [Related]  

  • 56. Synergistic antileukemic therapies in
    Sanchez-Martin M; Ambesi-Impiombato A; Qin Y; Herranz D; Bansal M; Girardi T; Paietta E; Tallman MS; Rowe JM; De Keersmaecker K; Califano A; Ferrando AA
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2006-2011. PubMed ID: 28174276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
    Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA-Binding Protein
    Loh XY; Sun QY; Ding LW; Mayakonda A; Venkatachalam N; Yeo MS; Silva TC; Xiao JF; Doan NB; Said JW; Ran XB; Zhou SQ; Dakle P; Shyamsunder P; Koh AP; Huang RY; Berman BP; Tan SY; Yang H; Lin DC; Koeffler HP
    Cancer Res; 2020 Jan; 80(2):219-233. PubMed ID: 31551365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.
    Ren W; Ye X; Su H; Li W; Liu D; Pirmoradian M; Wang X; Zhang B; Zhang Q; Chen L; Nie M; Liu Y; Meng B; Huang H; Jiang W; Zeng Y; Li W; Wu K; Hou Y; Wiman KG; Li Z; Zhang H; Peng R; Zhu S; Pan-Hammarström Q
    Blood; 2018 Jun; 131(24):2670-2681. PubMed ID: 29545328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
    de Matos Simoes R; Shirasaki R; Downey-Kopyscinski SL; Matthews GM; Barwick BG; Gupta VA; Dupéré-Richer D; Yamano S; Hu Y; Sheffer M; Dhimolea E; Dashevsky O; Gandolfi S; Ishiguro K; Meyers RM; Bryan JG; Dharia NV; Hengeveld PJ; Brüggenthies JB; Tang H; Aguirre AJ; Sievers QL; Ebert BL; Glassner BJ; Ott CJ; Bradner JE; Kwiatkowski NP; Auclair D; Levy J; Keats JJ; Groen RWJ; Gray NS; Culhane AC; McFarland JM; Dempster JM; Licht JD; Boise LH; Hahn WC; Vazquez F; Tsherniak A; Mitsiades CS
    Nat Cancer; 2023 May; 4(5):754-773. PubMed ID: 37237081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.